220 results on '"Sampat, Bhaven N."'
Search Results
2. Crisis Innovation: Historical Evidence, Insights, and Open Questions
3. The Economics of Crisis Innovation Policy : A Historical Perspective
4. Manual versus machine: How accurately does the Medical Text Indexer (MTI) classify different document types into disease areas?
5. WHOSE DRUGS ARE THESE?
6. Comment
7. America, Jump-Started: World War II R&D and the Takeoff of the US Innovation System
8. The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update.
9. The Government Patent Register: A New Resource for Measuring U.S. Government-Funded Patenting.
10. Public R&D Investments and Private-sector Patenting : Evidence from NIH Funding Rules
11. 8 What Happens in University-Industry Technology Transfer?
12. Unexpectedness in medical research
13. Ivory Tower and Industrial Innovation
14. The applied value of public investments in biomedical research
15. Secondary pharmaceutical patenting: A global perspective
16. Learning to Patent: Institutional Experience, Learning, and the Characteristics of U. S. University Patents after the Bayh-Dole Act, 1981-1992
17. How Do University Inventions Get into Practice?
18. Manual versus machine: An evaluation of the performance of the Medical Text Indexer (MTI) at classifying different document types by disease area
19. Second World War and the Direction of Medical Innovation
20. Intellectual Property Rights and Pharmaceuticals: The Case of Antibiotics
21. Doubling Down: Will Large Increases in the NIH Budget Promote More Meaningful Medical Innovation?
22. Patent Citations and the Economic Value of Patents : A Preliminary Assessment
23. The Bayh-Dole Act of 1980 and University-Industry Technology Transfer: A Model for Other OECD Governments?
24. Fixing The FDA’s Orange Book
25. THE NBER ORANGE BOOK DATASET: A USER’S GUIDE.
26. New Evidence on the Allocation of NIH Funds across Diseases
27. Mission-oriented biomedical research at the NIH
28. TRIPS Implementation and Secondary Pharmaceutical Patenting in Brazil and India
29. Challenges to India's Pharmaceutical Patent Laws
30. Evergreening, patent challenges, and effective market life in pharmaceuticals
31. The NBER Orange Book Dataset: A User's Guide
32. Crisis Innovation Policy from World War II to COVID-19
33. RESEARCH LOCALLY, DIFFUSE GLOBALLY? AMERICAN UNIVERSITIES, PATENTS AND GLOBAL PUBLIC HEALTH
34. When Do Applicants Search for Prior Art?
35. Las instituciones como factor que regula el desempeño económico
36. Innovation, Technical Change, and Patents in the Development Process: A Long-Term View1
37. Is Bayh-Dole Good for Developing Countries? Lessons from the U.S. Experience
38. University software ownership and litigation: a first examination.
39. The COVID-19 Innovation System
40. The Economics of Crisis Innovation Policy: A Historical Perspective
41. What Role Should Governments Play in Setting Rewards for Medical Innovation?
42. The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead
43. The Dynamics of Inattention in the (Baseball) Field
44. Crisis Innovation Policy from World War II to COVID-19
45. Is the patent office a rubber stamp?
46. The anatomy of medical school patenting
47. The Diffusion of Scientific Knowledge across Time and Space
48. The Bayh-Dole Act of 1980 and University--Industry Technology Transfer: A Model for Other OECD Governments?
49. 11 The Accumulation of Capabilities in Indian Pharmaceuticals and Software: The Roles that Patents Did (and Did Not) Play
50. Patenting and US academic research in the 20th century: The world before and after Bayh-Dole
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.